Reduced TNF-α and IFN-γ responses to Central Asian strain 1 and Beijing isolates of Mycobacterium tuberculosis in comparison with H37Rv strain

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 6, 2009, Pages 581-587

  Tanveer, Mahnaz ^a   Hasan, Zahra ^a   Kanji, Akbar ^a   Hussain, Rabia ^a   Hasan, Rumina ^a  

^a AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

Biological assay; Growth index; Interferon gamma; Mycobacterium tuberculosis; Pakistan; Tumour necrosis factor alpha

Indexed keywords

BCG VACCINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BACTERIAL GROWTH; BACTERIAL IMMUNITY; BACTERIAL STRAIN; BACTERIUM ISOLATE; BCG VACCINATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EX VIVO STUDY; FEMALE; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; LUNG TUBERCULOSIS; MALE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; STRAIN DIFFERENCE;

ADOLESCENT; ADULT; FEMALE; GENOTYPE; HUMANS; HYDROLASES; INTERFERON-GAMMA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PAKISTAN; PREVALENCE; SPECIES SPECIFICITY; TUBERCULOSIS; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

MYCOBACTERIUM TUBERCULOSIS;

EID: 67349096799     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2009.03.014     Document Type: Article

References (45)

1. Dye C., Watt C.J., Bleed D.M., Hosseini S.M., and Raviglione M.C. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence and deaths globally. JAMA 293 (2005) 2767-2775
2. Kochi A. The global tuberculosis situation and the new control strategy of the World Health Organization. Tubercle 72 (1991) 1-6
3. WHO. Global tuberculosis control: surveillance, planning, financing. WHO Report 2008. Geneva: World Health Organization; 2008. WHO/HTM/TB/2008.393.
4. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep 1991;40:585-91.
5. Fischl M.A., Daikos G.L., Uttamchandani R.B., Poblete R.B., Moreno J.N., Reyes R.R., et al. Clinical presentation and outcome of patients with HIV infection and tuberculosis caused by multiple-drug-resistant bacilli. Ann Intern Med 117 (1992) 184-190
6. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 (1995) 1339-1345
7. Ottenhoff T.H., Verreck F.A., Hoeve M.A., and van de Vosse E. Control of human host immunity to mycobacteria. Tuberculosis (Edinb) 85 (2005) 53-64
8. Flynn J.L., and Ernst J.D. Immune responses in tuberculosis. Curr Opin Immunol 12 (2000) 432-436
9. Stenger S., and Modlin R.L. T cell mediated immunity to Mycobacterium tuberculosis. Curr Opin Microbiol 2 (1999) 89-93
10. Juffermans N.P., Verbon A., van Deventer S.J., van Deutekom H., Belisle J.T., Ellis M.E., et al. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: a possible role for mycobacterial lipoarabinomannan. Infect Immun 67 (1999) 4295-4297
11. Lane B.R., Markovitz D.M., Woodford N.L., Rochford R., Strieter R.M., and Coffey M.J. TNF-alpha inhibits HIV-1 replication in peripheral blood monocytes and alveolar macrophages by inducing the production of RANTES and decreasing C-C chemokine receptor 5 (CCR5) expression. J Immunol 163 (1999) 3653-3661
12. Manca C., Tsenova L., Bergtold A., Freeman S., Tovey M., Musser J.M., et al. Virulence of a Mycobacterium tuberculosis clinical isolate in mice is determined by failure to induce Th1 type immunity and is associated with induction of IFN-alpha/beta. Proc Natl Acad Sci USA 98 (2001) 5752-5757
13. Hasan Z., Mahmood A., Zafar S., Khan A.A., and Hussain R. Leprosy patients with lepromatous disease have an up-regulated IL-8 response that is unlinked to TNF-alpha responses. Int J Lepr Other Mycobact Dis 72 (2004) 35-44
14. Wong K.C., Leong W.M., Law H.K., Ip K.F., Lam J.T., Yuen K.Y., et al. Molecular characterization of clinical isolates of Mycobacterium tuberculosis and their association with phenotypic virulence in human macrophages. Clin Vaccine Immunol 14 (2007) 1279-1284
15. Lopez B., Aguilar D., Orozco H., Burger M., Espitia C., Ritacco V., et al. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133 (2003) 30-37
16. Zhang M., Gong J., Lin Y., and Barnes P.F. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect Immun 66 (1998) 794-799
17. Theus S.A., Cave M.D., and Eisenach K.D. Intracellular macrophage growth rates and cytokine profiles of Mycobacterium tuberculosis strains with different transmission dynamics. J Infect Dis 191 (2005) 453-460
18. Newton S.M., Smith R.J., Wilkinson K.A., Nicol M.P., Garton N.J., Staples K.J., et al. A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci USA 103 (2006) 15594-15598
19. Janulionis E., Sofer C., Schwander S.K., Nevels D., Kreiswirth B., Shashkina E., et al. Survival and replication of clinical Mycobacterium tuberculosis isolates in the context of human innate immunity. Infect Immun 73 (2005) 2595-2601
20. Manca C., Tsenova L., Barry III C.E., Bergtold A., Freeman S., Haslett P.A., et al. Mycobacterium tuberculosis CDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J Immunol 162 (1999) 6740-6746
21. Theus S.A., Cave M.D., and Eisenach K.D. Activated THP-1 cells: an attractive model for the assessment of intracellular growth rates of Mycobacterium tuberculosis isolates. Infect Immun 72 (2004) 1169-1173
22. Hasan Z., Ashraf M., Tayyebi A., and Hussain R. M. leprae inhibits apoptosis in THP-1 cells by downregulation of Bad and Bak and upregulation of Mcl-1 gene expression. BMC Microbiol 6 (2006) 78
23. Monahan I.M., Betts J., Banerjee D.K., and Butcher P.D. Differential expression of mycobacterial proteins following phagocytosis by macrophages. Microbiology 147 (2001) 459-471
24. Hussain R., Shiratsuchi H., Ellner J.J., and Wallis R.S. PPD-specific IgG1 antibody subclass upregulate tumour necrosis factor expression in PPD-stimulated monocytes: possible link with disease pathogenesis in tuberculosis. Clin Exp Immunol 119 (2000) 449-455
25. Hussain R., Shiratsuchi H., Phillips M., Ellner J., and Wallis R.S. Opsonizing antibodies (IgG1) up-regulate monocyte proinflammatory cytokines tumour necrosis factor-alpha (TNF-alpha) and IL-6 but not anti-inflammatory cytokine IL-10 in mycobacterial antigen-stimulated monocytes - implications for pathogenesis. Clin Exp Immunol 123 (2001) 210-218
26. Dockrell H.M., and Weir R.E. Whole blood cytokine assays: a new generation of diagnostic tests for tuberculosis?. Int J Tuberc Lung Dis 2 (1998) 441-442
27. Elliott A.M., Hodsdon W.S., Kyosiimire J., Quigley M.A., Nakiyingi J.S., Namujju P.B., et al. Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective study. Trans R Soc Trop Med Hyg 98 (2004) 660-670
28. Hasan Z., Tanveer M., Kanji A., Hasan Q., Ghebremichael S., and Hasan R. Spoligotyping of Mycobacterium tuberculosis isolates from Pakistan reveals predominance of Central Asian Strain 1 and Beijing isolates. J Clin Microbiol 44 (2006) 1763-1768
29. Sola C., Filliol I., Gutierrez M.C., Mokrousov I., Vincent V., and Rastogi N. Spoligotype database of Mycobacterium tuberculosis: biogeographic distribution of shared types and epidemiologic and phylogenetic perspectives. Emerg Infect Dis 7 (2001) 390-396
30. Gutierrez M.C., Ahmed N., Willery E., Narayanan S., Hasnain S.E., Chauhan D.S., et al. Predominance of ancestral lineages of Mycobacterium tuberculosis in India. Emerg Infect Dis 12 (2006) 1367-1374
31. Glynn J.R., Whiteley J., Bifani P.J., Kremer K., and van Soolingen D. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerg Infect Dis 8 (2002) 843-849
32. Stokes R.W., and Doxsee D. The receptor-mediated uptake, survival, replication, and drug sensitivity of Mycobacterium tuberculosis within the macrophage-like cell line THP-1: a comparison with human monocyte-derived macrophages. Cell Immunol 197 (1999) 1-9
33. Hasan Z., Shah B.H., Mahmood A., Young D.B., and Hussain R. The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes. Tuberculosis (Edinb) 83 (2003) 299-309
34. Hussain R., Kaleem A., Shahid F., Dojki M., Jamil B., Mehmood H., et al. Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264 (2002) 95-108
35. Toungoussova O.S., Caugant D.A., Sandven P., Mariandyshev A.O., and Bjune G. Impact of drug resistance on fitness of Mycobacterium tuberculosis strains of the W-Beijing genotype. FEMS Immunol Med Microbiol 42 (2004) 281-290
36. Becton D. BACTEC TB system product and procedure manual (1989), Becton Dickinson, Franklin Lakes, NJ p. 11-5
37. Tanveer M., Hasan Z., Siddiqui A.R., Ali A., Kanji A., Ghebremicheal S., et al. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan. BMC Infect Dis 8 (2008) 171
38. van Crevel R., Ottenhoff T.H., and van der Meer J.W. Innate immunity to Mycobacterium tuberculosis. Clin Microbiol Rev 15 (2002) 294-309
39. Bean A.G., Roach D.R., Briscoe H., France M.P., Korner H., Sedgwick J.D., et al. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J Immunol 162 (1999) 3504-3511
40. Reed M.B., Domenech P., Manca C., Su H., Barczak A.K., Kreiswirth B.N., et al. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 (2004) 84-87
41. Wu S., Howard S.T., Lakey D.L., Kipnis A., Samten B., Safi H., et al. The principal sigma factor sigA mediates enhanced growth of Mycobacterium tuberculosis in vivo. Mol Microbiol 51 (2004) 1551-1562
42. Dahl K.E., Shiratsuchi H., Hamilton B.D., Ellner J.J., and Toossi Z. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis. Infect Immun 64 (1996) 399-405
43. Manca C., Reed M.B., Freeman S., Mathema B., Kreiswirth B., Barry III C.E., et al. Differential monocyte activation underlies strain-specific Mycobacterium tuberculosis pathogenesis. Infect Immun 72 (2004) 5511-5514
44. Freeman S., Post F.A., Bekker L.G., Harbacheuski R., Steyn L.M., Ryffel B., et al. Mycobacterium tuberculosis H37Ra and H37Rv differential growth and cytokine/chemokine induction in murine macrophages in vitro. J Interferon Cytokine Res 26 (2006) 27-33
45. Rajakumar K., Shafi J., Smith R.J., Stabler R.A., Andrew P.W., Modha D., et al. Use of genome level-informed PCR as a new investigational approach for analysis of outbreak-associated Mycobacterium tuberculosis isolates. J Clin Microbiol 42 (2004) 1890-1896